The findings highlight the need for public-health strategies aimed at mitigating dementia risk and promoting healthy aging across diverse populations, researchers said. “I think ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
said other states with similar programs have seen earlier detection and treatment, which can slow the progression of dementia. “This position can both provide consistency — this awareness and ...
Some results have been hidden because they may be inaccessible to you